| 487738 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
miR-410-3p regulates proliferation and apoptosis of fibroblast-like synoviocytes by targeting YY1 in rheumatoid arthritis |
2019-11-01 |
10.1016/j.biopha.2019.109426 |
Wang YueJiao, Jiao Ting, Fu WenYi, Zhao Shuai, Yang LiLi, Xu NeiLi, Zhang Ning |
| 487737 |
BMJ OPEN |
Medication safety problems priorities in community pharmacy in Saudi Arabia: a multi-stakeholder Delphi study using the human factors framework |
2019-11-01 |
10.1136/bmjopen-2019-032419 |
Al Juffali Lobna Abdullah, Knapp Peter, Al-Aqeel Sinaa, Watson Margaret C |
| 487736 |
PHARMACEUTICS |
Nanomedicine Against Aβ Aggregation by β–Sheet Breaker Peptide Delivery: In Vitro Evidence |
2019-11-01 |
10.3390/pharmaceutics11110572 |
Pederzoli , Ruozi , Duskey , Hagmeyer , Sauer , Grabrucker , Coelho , Oddone , Ottonelli , Daini , Zoli , Vandelli , Tosi , Grabrucker |
| 487735 |
BMJ OPEN |
The structure and predictive value of intrinsic capacity in a longitudinal study of ageing |
2019-11-01 |
10.1136/bmjopen-2018-026119 |
Beard John R, Jotheeswaran A T, Cesari Matteo, Araujo de Carvalho Islene |
| 487734 |
BMJ OPEN |
Reliability and validity of the Japanese version of the Ocular Surface Disease Index for dry eye disease |
2019-11-01 |
10.1136/bmjopen-2019-033940 |
Midorikawa-Inomata Akie, Inomata Takenori, Nojiri Shuko, Nakamura Masahiro, Iwagami Masao, Fujimoto Keiichi, Okumura Yuichi, Iwata Nanami, Eguchi Atsuko, Hasegawa Hitomi, Kinouchi Hikaru, Murakami Akira, Kobayashi Hiroyuki |
| 487733 |
CLINICAL LUNG CANCER |
A Population-Based Study of Incidence and Survival of 1588 Thymic Malignancies: Results From the California Cancer Registry. | A Population-Based Study of Incidence and Survival of 1588 Thymic Malignancies: Results From the California Cancer Registry |
2019-11-01 |
10.1016/j.cllc.2019.06.005 |
Benjamin David J., Klapheke Amy, Lara Primo N., Cress Rosemary D., Riess Jonathan W. |
| 487732 |
FRONTIERS IN ONCOLOGY |
Lactate in the Regulation of Tumor Microenvironment and Therapeutic Approaches |
2019-11-01 |
10.3389/fonc.2019.01143 |
de la Cruz-López Karen G., Castro-Muñoz Leonardo Josué, Reyes-Hernández Diego O., García-Carrancá Alejandro, Manzo-Merino Joaquín |
| 487731 |
NEURO-ONCOLOGY |
CMET-41. OUTCOMES FOLLOWING STEREOTACTIC RADIOSURGERY (SRS) FOR LIMITED BRAIN METASTASES - AN AUSTRALIAN SINGLE INSTITUTIONAL EXPERIENCE | CMET-41. OUTCOMES FOLLOWING STEREOTACTIC RADIOSURGERY (SRS) FOR LIMITED BRAIN METASTASES - AN AUSTRALIAN SINGLE INST |
2019-11-01 |
10.1093/neuonc/noz175.242 |
Shen Lilly, Loon Ong Wee, Farrugia Briana, Seeley Anna, Augusto Gonzalvo Carlos, Wada Morikatsu |
| 487730 |
NEURO-ONCOLOGY |
RTHP-20. MULTI-INSTITUTIONAL ANALYSIS OF HIGH-RISK WHO GRADE II OLIGODENDROGLIOMA TREATED WITH ADJUVANT RADIOTHERAPY PLUS TEMOZOLOMIDE (TMZ) VERSUS PROCARBAZINE, LOMUSTINE, AND VINCRISTINE (PCV) | RTHP-20. MULTI-INSTITUTIONAL ANALYSIS OF HIGH-RISK WHO GRA |
2019-11-01 |
10.1093/neuonc/noz175.891 |
Tom Martin, Routman David, Laack Nadia, Frechette Kelsey, Park Deborah, (Auston) Wei Wei, Leyrer Marc, Peereboom David, Ahluwalia Manmeet, Chao Samuel, Suh John, Murphy Erin |
| 487729 |
NEURO-ONCOLOGY |
IMMU-30. UTILIZING A NOVEL MASS CYTOMETRY-BASED IMMUNOMONITORING PLATFORM FOR THE CHARACTERIZATION OF VACCINE-REACTIVE, EPITOPE-SPECIFIC CD8+ T-CELLS IN HLA-A*0201+ PATIENTS WITH K27M+ DIFFUSE MIDLINE GLIOMAS | IMMU-30. UTILIZING A NOVEL MASS CYTOMETRY-BA |
2019-11-01 |
10.1093/neuonc/noz175.522 |
Taitt Jared, Watchmaker Payal, Nejo Takahide, Almeida Neil, Okada Kaori, Shahin Maryam, Gilbert Ryan, Mueller Sabine, Okada Hideho |
